Angiotensin-(1-7): a new therapeutic strategy in the management of atrial fibrillation.

Atrial fibrillation (AF) is one of the most common cardiac arrhythmia, especially in the elderly population, and contributes substantially to cardiac morbidity and mortality [1,2]. In spite of the development of novel therapeutic approaches, including the radiofrequency catheter ablation, the management of AF remains an important and difficult task. During… CONTINUE READING